112 related articles for article (PubMed ID: 32506171)
1. Missense Variants in Hypoxia-Induced VEGFA/VEGFR2 Signaling Predict the Outcome of Large Artery Atherosclerotic Stroke.
Li Z; Wang M; Gu J; Zhao L; Guo Y; Zhang Z; Liu X
Cell Mol Neurobiol; 2021 Aug; 41(6):1217-1225. PubMed ID: 32506171
[TBL] [Abstract][Full Text] [Related]
2. Association of Genetic Polymorphisms on VEGFA and VEGFR2 With Risk of Coronary Heart Disease.
Liu D; Song J; Ji X; Liu Z; Cong M; Hu B
Medicine (Baltimore); 2016 May; 95(19):e3413. PubMed ID: 27175642
[TBL] [Abstract][Full Text] [Related]
3. The Relation of VEGFA, VEGFR2, VEGI, and HIF1A Genetic Variants and Their Serum Protein Levels with Breast Cancer in Egyptian Patients.
Abdelgalil AA; Monir R; Elmetwally M; Ghattas MH; Bazeed FB; Mesbah NM; Abo-Elmatty DM; Mehanna ET
Biochem Genet; 2024 Feb; 62(1):547-573. PubMed ID: 37392242
[TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of vascular endothelial growth factor (VEGFA) and VEGF receptor (VEGFR2) gene polymorphism on the treatment outcome following imatinib therapy.
Kim DH; Xu W; Kamel-Reid S; Liu X; Jung CW; Kim S; Lipton JH
Ann Oncol; 2010 Jun; 21(6):1179-1188. PubMed ID: 19875757
[TBL] [Abstract][Full Text] [Related]
5. VEGFA and VEGFR2 genetic polymorphisms and survival in patients with diffuse large B cell lymphoma.
Kim MK; Suh C; Chi HS; Cho HS; Bae YK; Lee KH; Lee GW; Kim IS; Eom HS; Kong SY; Bae SH; Ryoo HM; Shin IH; Mun YC; Chung H; Hyun MS
Cancer Sci; 2012 Mar; 103(3):497-503. PubMed ID: 22129133
[TBL] [Abstract][Full Text] [Related]
6. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
[TBL] [Abstract][Full Text] [Related]
8. The association of genetic polymorphisms of hypoxia inducible factor-1 alpha and vascular endothelial growth factor with increased risk of chronic obstructive pulmonary disease: A case-control study.
Yu ZG; Wang BZ; Cheng ZZ
Kaohsiung J Med Sci; 2017 Sep; 33(9):433-441. PubMed ID: 28865600
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in VEGFA and VEGFR2 genes associated with coronary heart disease susceptibility and severity.
Hajer F; Hana S; Saoussen C; Abdelhak F; Nadia B; Ameni D; Habib G; Hassen BA; Amel HK
Mol Biol Rep; 2023 Dec; 50(12):10169-10177. PubMed ID: 37924452
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of the relationship between VEGFR2 polymorphisms and atherosclerotic cardiovascular diseases.
Wang L; Ge H; Peng L; Wang B
Clin Cardiol; 2019 Oct; 42(10):860-865. PubMed ID: 31339592
[TBL] [Abstract][Full Text] [Related]
11. Variants in 3p24.3 predicts the risk of early neurological deterioration in large artery atherosclerotic stroke.
Huang X; Ye Q; Zhu Z; Chen Y; Xia N; Chen R; Geng W; Ye Z
Brain Res; 2024 Jun; 1833():148867. PubMed ID: 38499234
[TBL] [Abstract][Full Text] [Related]
12. Association of Genetic Polymorphisms on Vascular Endothelial Growth Factor and its Receptor Genes with Susceptibility to Coronary Heart Disease.
Li L; Pan Y; Dai L; Liu B; Zhang D
Med Sci Monit; 2016 Jan; 22():31-40. PubMed ID: 26726843
[TBL] [Abstract][Full Text] [Related]
13. Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab.
Loupakis F; Cremolini C; Yang D; Salvatore L; Zhang W; Wakatsuki T; Bohanes P; Schirripa M; Benhaim L; Lonardi S; Antoniotti C; Aprile G; Graziano F; Ruzzo A; Lucchesi S; Ronzoni M; De Vita F; Tonini G; Falcone A; Lenz HJ
PLoS One; 2013; 8(7):e66774. PubMed ID: 23861747
[TBL] [Abstract][Full Text] [Related]
14. HDAC9 Polymorphisms Predict Susceptibility, Severity, and Short-Term Outcome of Large Artery Atherosclerotic Stroke in Chinese Population.
Wang M; Gu M; Li Z; Sun B; Cheng X; Dai Z; Li S; Xiao L; Zhao M; Wang Z; Lin Y; Liu Y; Xu J; Zhang Z; Liu X
J Mol Neurosci; 2019 Jan; 67(1):165-171. PubMed ID: 30565168
[TBL] [Abstract][Full Text] [Related]
15. VEGFA and VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy: comparison of age-related macular degeneration treatments trials (CATT).
Hagstrom SA; Ying GS; Pauer GJ; Sturgill-Short GM; Huang J; Maguire MG; Martin DF;
JAMA Ophthalmol; 2014 May; 132(5):521-7. PubMed ID: 24652518
[TBL] [Abstract][Full Text] [Related]
16. Implication of VEGFR2 in systemic lupus erythematosus: a combined genetic and structural biological approach.
Vazgiourakis VM; Zervou MI; Eliopoulos E; Sharma S; Sidiropoulos P; Franek BS; Myrthianou E; Melissourgaki M; Niewold TB; Boumpas DT; Goulielmos GN
Clin Exp Rheumatol; 2013; 31(1):97-102. PubMed ID: 23111153
[TBL] [Abstract][Full Text] [Related]
17. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
[TBL] [Abstract][Full Text] [Related]
18. Two Novel SNPs in the PLCL2 Gene Associated with Large Artery Atherosclerotic Stroke Identified by Fine-Mapping.
Huang X; Zhu Z; Chen Y; Li J; Xia N; Chen S; Geng W; Ye Z
J Mol Neurosci; 2020 Apr; 70(4):496-503. PubMed ID: 31970634
[TBL] [Abstract][Full Text] [Related]
19. Endorepellin laminin-like globular 1/2 domains bind Ig3-5 of vascular endothelial growth factor (VEGF) receptor 2 and block pro-angiogenic signaling by VEGFA in endothelial cells.
Willis CD; Poluzzi C; Mongiat M; Iozzo RV
FEBS J; 2013 May; 280(10):2271-84. PubMed ID: 23374253
[TBL] [Abstract][Full Text] [Related]
20. [Association of VEGFR2 gene polymorphisms with the effect of L-dopa and dyskinesia complications].
Yan Y; Qian L; Fang S; Gong Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Nov; 40(11):1199-204. PubMed ID: 26643422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
